In summary, our study identifies an epigenetic mechanism by which the main eBL risk factors (EBV infection and AFB1 exposure) bring about the silencing of a cancer-related gene (TGFBI) and provides insight into molecular events potentially contributing to eBL development. This evidence concerns the gene TGFBI and cancer.